Oscar Health Surges After ACA Subsidy Extension and Analyst Upgrade
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 11 2026
0mins
Should l Buy OSCR?
Source: Yahoo Finance
Oscar Health Inc. rose 6.69% in after-hours trading to $18.04 per share, reflecting optimistic market sentiment regarding the company's future, particularly in light of the ACA subsidy extension.
The U.S. House of Representatives passed a bill extending Affordable Care Act subsidies for three more years, which is expected to lower health insurance costs for millions of Americans, significantly improving Oscar Health's business outlook due to its heavy reliance on the ACA exchange market. Barclays upgraded Oscar's stock rating from 'Underweight' to 'Equal-Weight' and raised its price target from $13 to $18, further fueling the stock's rise and indicating strong market confidence in its future performance.
Oscar's stock has increased 16.71% year-to-date, showcasing strong performance in the overall market, with positive price trends in both short and long terms despite poor momentum rankings.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OSCR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OSCR
Wall Street analysts forecast OSCR stock price to rise
8 Analyst Rating
1 Buy
4 Hold
3 Sell
Hold
Current: 11.730
Low
11.00
Averages
15.75
High
25.00
Current: 11.730
Low
11.00
Averages
15.75
High
25.00
About OSCR
Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Oscar Health Stock Down but Growth Potential Remains Strong
- Market Share Growth: Oscar Health's membership surged to 3.4 million in 2026, up from 2 million at the end of 2025, demonstrating strong competitiveness in the individual market despite challenges from reduced subsidies.
- Profitability Outlook: The company anticipates operating income between $250 million and $450 million for 2026, which, while a small margin of its projected $18.7 billion to $19 billion revenue, indicates potential for improved profitability.
- Low Market Valuation: With a current market cap of $3.2 billion, Oscar Health trades at less than 10 times the high end of its 2026 operating earnings guidance, suggesting the stock is undervalued and presents a good opportunity for long-term investors.
- Tech-Driven Competitive Edge: As a technology-forward health insurer, Oscar Health's innovations in customer experience allow it to stand out in a challenging environment, and despite rising healthcare costs, its market share continues to grow.
See More
Oscar Health Rapidly Gains Market Share Amidst Challenges
- Market Share Growth: Oscar Health's membership surged to 3.4 million after the 2026 enrollment period, up from 2 million at the end of 2025, demonstrating its strong competitive position despite challenges from reduced subsidies.
- Profitability Outlook: The company anticipates operating income between $250 million and $450 million for 2026, which, while a slim margin on its revenue expectations of $18.7 billion to $19 billion, indicates significant future growth potential.
- Stock Price Decline: Currently, Oscar Health's stock trades at a market cap of $3.2 billion, or less than 10 times the high end of its 2026 operating earnings guidance, suggesting the stock is undervalued and presents a good opportunity for long-term investors.
- Industry Pressures: Despite Oscar Health's success in gaining market share, the overall healthcare insurance sector has seen stock prices decline due to rising healthcare costs and uncertainty surrounding ACA subsidies, raising investor concerns.
See More
Geopolitical Conflict Impacts Oil Prices and Stock Market
- Market Volatility Intensifies: The geopolitical conflict in Iran has heightened concerns over oil prices and global inflation, leading the Nasdaq-100 index to drop over 10%, reflecting market anxiety about future economic conditions.
- Oscar Health Growth Potential: Oscar Health anticipates reaching 3.4 million members in 2026, and despite customer churn risks, the company expects to achieve $250 million to $450 million in operating income, demonstrating resilience in an economic downturn.
- Adyen Market Share Gains: Adyen, a global payment processor, has seen its stock drop over 50% from highs, yet its revenue grew 21% year-over-year in the second half of last year, with EBITDA margins at 55%, indicating strong long-term investment potential.
- Remitly Digital Transfer Advantage: Remitly Global is rapidly gaining market share in the foreign money transfer sector, with revenue increasing 26% year-over-year to $442 million and a record operating margin of 9%, showcasing the strength of its business model.
See More
HealthEquity Appoints New Board Member
- Board Expansion: HealthEquity announced the election of William Gassen, CEO of Sanford Health, to its board effective March 26, 2026, increasing the board to 10 members, 8 of whom are independent, thereby enhancing corporate governance.
- Rich Industry Experience: Gassen has served as CEO of Sanford Health since November 2020, leading the nation's largest rural health system, and his insights into healthcare delivery and financing will strengthen HealthEquity's ability to navigate challenges in the healthcare system.
- Focus on Affordability: Gassen emphasized that affordability in healthcare remains a significant challenge for many families and employers, and HealthEquity plays a crucial role in helping individuals prepare for and make informed decisions about healthcare spending, reinforcing the company's market position.
- Educational Background and Credentials: Gassen holds a bachelor's degree in criminal justice and a J.D. from the University of South Dakota, and has held several senior leadership roles in healthcare, providing a strong foundation to support HealthEquity's strategic development.
See More
HealthEquity Appoints New Board Member to Enhance Governance
- Board Expansion: HealthEquity announced the election of William Gassen, CEO of Sanford Health, to its board effective March 26, 2026, increasing the board to 10 members, 8 of whom are independent, thereby enhancing corporate governance.
- Rich Industry Experience: Gassen's leadership experience at Sanford Health will provide HealthEquity with deep insights into healthcare delivery and financing, helping the company better address the challenges faced by consumers, providers, and employers in the healthcare system.
- Focus on Affordability: Gassen emphasized that affordability in healthcare remains a significant challenge for many families and employers, and HealthEquity plays a crucial role in helping people prepare for healthcare expenses, further solidifying the company's market position.
- Educational Background and Professional Experience: Gassen holds a bachelor's degree in criminal justice and a J.D. from the University of South Dakota, and has held several senior leadership roles at Sanford Health, bringing a diverse perspective to the board.
See More
HEALTHEQUITY NAMES BILL GASSEN, CEO OF SANFORD HEALTH, TO ITS BOARD OF DIRECTORS
Health Equity Appointment: Bill Gassen has been appointed as the CEO of Sanford Health, focusing on health equity initiatives.
Board of Directors: Gassen will also serve on the Board of Directors, contributing to strategic decisions and governance.
See More
Oscar Health Stock Down but Growth Potential Remains Strong
- Market Share Growth: Oscar Health's membership surged to 3.4 million in 2026, up from 2 million at the end of 2025, demonstrating strong competitiveness in the individual market despite challenges from reduced subsidies.
- Profitability Outlook: The company anticipates operating income between $250 million and $450 million for 2026, which, while a small margin of its projected $18.7 billion to $19 billion revenue, indicates potential for improved profitability.
- Low Market Valuation: With a current market cap of $3.2 billion, Oscar Health trades at less than 10 times the high end of its 2026 operating earnings guidance, suggesting the stock is undervalued and presents a good opportunity for long-term investors.
- Tech-Driven Competitive Edge: As a technology-forward health insurer, Oscar Health's innovations in customer experience allow it to stand out in a challenging environment, and despite rising healthcare costs, its market share continues to grow.
See More
Oscar Health Rapidly Gains Market Share Amidst Challenges
- Market Share Growth: Oscar Health's membership surged to 3.4 million after the 2026 enrollment period, up from 2 million at the end of 2025, demonstrating its strong competitive position despite challenges from reduced subsidies.
- Profitability Outlook: The company anticipates operating income between $250 million and $450 million for 2026, which, while a slim margin on its revenue expectations of $18.7 billion to $19 billion, indicates significant future growth potential.
- Stock Price Decline: Currently, Oscar Health's stock trades at a market cap of $3.2 billion, or less than 10 times the high end of its 2026 operating earnings guidance, suggesting the stock is undervalued and presents a good opportunity for long-term investors.
- Industry Pressures: Despite Oscar Health's success in gaining market share, the overall healthcare insurance sector has seen stock prices decline due to rising healthcare costs and uncertainty surrounding ACA subsidies, raising investor concerns.
See More
Geopolitical Conflict Impacts Oil Prices and Stock Market
- Market Volatility Intensifies: The geopolitical conflict in Iran has heightened concerns over oil prices and global inflation, leading the Nasdaq-100 index to drop over 10%, reflecting market anxiety about future economic conditions.
- Oscar Health Growth Potential: Oscar Health anticipates reaching 3.4 million members in 2026, and despite customer churn risks, the company expects to achieve $250 million to $450 million in operating income, demonstrating resilience in an economic downturn.
- Adyen Market Share Gains: Adyen, a global payment processor, has seen its stock drop over 50% from highs, yet its revenue grew 21% year-over-year in the second half of last year, with EBITDA margins at 55%, indicating strong long-term investment potential.
- Remitly Digital Transfer Advantage: Remitly Global is rapidly gaining market share in the foreign money transfer sector, with revenue increasing 26% year-over-year to $442 million and a record operating margin of 9%, showcasing the strength of its business model.
See More
HealthEquity Appoints New Board Member
- Board Expansion: HealthEquity announced the election of William Gassen, CEO of Sanford Health, to its board effective March 26, 2026, increasing the board to 10 members, 8 of whom are independent, thereby enhancing corporate governance.
- Rich Industry Experience: Gassen has served as CEO of Sanford Health since November 2020, leading the nation's largest rural health system, and his insights into healthcare delivery and financing will strengthen HealthEquity's ability to navigate challenges in the healthcare system.
- Focus on Affordability: Gassen emphasized that affordability in healthcare remains a significant challenge for many families and employers, and HealthEquity plays a crucial role in helping individuals prepare for and make informed decisions about healthcare spending, reinforcing the company's market position.
- Educational Background and Credentials: Gassen holds a bachelor's degree in criminal justice and a J.D. from the University of South Dakota, and has held several senior leadership roles in healthcare, providing a strong foundation to support HealthEquity's strategic development.
See More
HealthEquity Appoints New Board Member to Enhance Governance
- Board Expansion: HealthEquity announced the election of William Gassen, CEO of Sanford Health, to its board effective March 26, 2026, increasing the board to 10 members, 8 of whom are independent, thereby enhancing corporate governance.
- Rich Industry Experience: Gassen's leadership experience at Sanford Health will provide HealthEquity with deep insights into healthcare delivery and financing, helping the company better address the challenges faced by consumers, providers, and employers in the healthcare system.
- Focus on Affordability: Gassen emphasized that affordability in healthcare remains a significant challenge for many families and employers, and HealthEquity plays a crucial role in helping people prepare for healthcare expenses, further solidifying the company's market position.
- Educational Background and Professional Experience: Gassen holds a bachelor's degree in criminal justice and a J.D. from the University of South Dakota, and has held several senior leadership roles at Sanford Health, bringing a diverse perspective to the board.
See More
HEALTHEQUITY NAMES BILL GASSEN, CEO OF SANFORD HEALTH, TO ITS BOARD OF DIRECTORS
Health Equity Appointment: Bill Gassen has been appointed as the CEO of Sanford Health, focusing on health equity initiatives.
Board of Directors: Gassen will also serve on the Board of Directors, contributing to strategic decisions and governance.
See More
